한글목차

보툴리눔증의 동향과 예측

세계 보툴리눔증 시장은 2024년부터 2030년까지 연평균 복합 성장률(CAGR) 6.6%로 성장할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 보툴리눔증의 발병률 증가와 의료 기술 분야의 진보입니다. 보툴리눔증 세계 시장의 미래는 소매 약국 시장과 온라인 상점 시장에 기회가 있고 유망시되고 있습니다.

보툴리눔증의 부문별 시장

보툴리눔증 세계 시장에 대해 독소 유형별, 치료 유형별, 의약품 유통 채널별, 최종 용도별, 지역별 예측을 제공합니다.

보툴리눔증 시장 인사이트

Lucintel사의 예측에서는 A형 보툴리눔 제제가 예측 기간 중에 높은 성장을 이룰 전망입니다.

이 시장에서 처방약과 건강 관리 제품에 대한 액세스가 널리 보급되어 소매 약국이 계속 큰 부문이 될 것입니다.

북미는 이 질병에 대한 인식이 높아지고 있어 고급 치료 설비를 용이하게 이용할 수 있기 때문에 예측 기간을 통해 최대의 지역이 될 것입니다.

FAQ

Q1. 시장의 성장 예측은 :

A1. 세계 보툴리눔증 시장은 2024년부터 2030년에 걸쳐 CAGR 6.6%를 나타낼 것으로 예측됩니다.

Q2. 시장 성장에 영향을 미치는 주요 촉진요인은 :

A2. 이 시장의 주요 촉진요인은 보툴리눔증의 이환율 상승과 의료기술 분야의 진보입니다.

Q3. 시장의 주요 부문은 :

A3. 보툴리눔증 시장의 미래는 소매 약국과 온라인 상점 시장에서의 기회에 의해 유망시되고 있습니다.

Q4. 시장의 주요 기업은 :

A4. 보툴리눔증 주요 기업은 다음과 같습니다.

• Allergan
• Pfizer
• AlphaVax
• Microbiotix
• Molecular Targeting Technologies
• Ipsen Technologies
• Galderma

Q5. 앞으로 가장 큰 시장 부문은 :

A5.Lucintel은 A형 보툴리눔균이 예측 기간 동안 높은 성장을 이룰 것으로 예측했습니다.

Q6. 시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은:

A6. 북미는 보툴리눔증에 대한 인식이 높아지고 있으며, 고급 치료시설을 쉽게 이용할 수 있기 때문에 예측기간 중에도 가장 규모가 큰 지역입니다.

Q7. 보고서 사용자 정의는 가능한가?

A7. 그렇습니다, Lucintel는 추가 비용 없이 10% 주문을 받아서 만듭니다.

목차

제1장 주요 요약

제2장 세계 보툴리눔증 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계 보툴리눔증 시장 동향(2018-2023년)과 예측(2024-2030년)
• 독소 유형별 보툴리눔증 세계 시장
  • 보툴리눔균 A형
  • 보툴리눔균 B형
• 치료 유형별 보툴리눔증 세계 시장
  • 항독소
  • 면밀한 기도관리
  • 완하제
  • 폴리 카테터
  • 기타
• 의약품 유통 채널별 보툴리눔증 세계 시장
  • 소매 약국
  • 온라인 스토어
• 최종 용도별 보툴리눔증 세계 시장
  • 병원 및 클리닉
  • 기타

제4장 지역별 시장 동향과 예측 분석(2018-2023년)

• 지역별 보툴리눔증 세계 시장
• 북미의 보툴리눔증 시장
• 유럽의 보툴리눔증 시장
• 아시아태평양 보툴리눔증 시장
• 기타 지역 보툴리눔증 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 독소유형별로 본 세계의 보툴리눔증 시장의 성장 기회
  • 치료 유형별 세계 보툴리눔증 시장의 성장 기회
  • 의약품 유통 채널별 세계 보툴리눔증 시장의 성장 기회
  • 최종 용도별 세계 보툴리눔증 시장의 성장 기회
  • 지역별 세계의 보툴리눔증 시장의 성장 기회
• 세계 보툴리눔증 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계 보툴리눔증 시장의 능력 확대
  • 세계 보툴리눔증 시장에서의 합병, 인수, 합작 사업
  • 인증 및 라이선싱

제7장 주요 기업의 기업 프로파일

• Allergan
• Pfizer
• AlphaVax
• Microbiotix
• Molecular Targeting Technologies
• Ipsen Technologies
• Galderma

영문목차

Botulism Illness Trends and Forecast

The future of the global botulism illness market looks promising with opportunities in the retail pharmacy and online store markets. The global botulism illness market is expected to grow with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are rising incidence of botulism and progress in the field of medical technologies.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Botulism Illness by Segment

The study includes a forecast for the global botulism illness by toxin type, treatment type, drug distribution channel, end use, and region.

Botulism Illness Market by Toxin Type [Shipment Analysis by Value from 2018 to 2030]:

• Botulinum Type A
• Botulinum Type B

Botulism Illness Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

• Antitoxins
• Meticulous Airway Management
• Cathartics
• Foley Catheter
• Others

Botulism Illness Market by Drug Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Retail Pharmacy
• Online Stores

Botulism Illness Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Others

Botulism Illness Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Botulism Illness Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies botulism illness companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the botulism illness companies profiled in this report include-

• Allergan
• Pfizer
• AlphaVax
• Microbiotix
• Molecular Targeting Technologies
• Ipsen Technologies
• Galderma

Botulism Illness Market Insights

Lucintel forecasts that botulinum type A is expected to witness higher growth over the forecast period.

Within this market, retail pharmacy will remain larger segment due to widespread accessibility for prescription medication and healthcare products.

North America will remain the largest region over the forecast period due to increasing awareness about the disease and easy availability of advanced treatment facilities in the region.

Features of the Global Botulism Illness Market

Market Size Estimates: Botulism illness market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Botulism illness market size by various segments, such as by toxin type, treatment type, drug distribution channel, end use, and region in terms of value ($B).

Regional Analysis: Botulism illness market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different toxin types, treatment types, drug distribution channels, end uses, and regions for the botulism illness market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the botulism illness market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for botulism illness market?

Answer: The global botulism illness market is expected to grow with a CAGR of 6.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the botulism illness market?

Answer: The major drivers for this market are rising incidence of botulism and progress in the field of medical technologies.

Q3. What are the major segments for botulism illness market?

Answer: The future of the botulism illness market looks promising with opportunities in the retail pharmacy and online store markets.

Q4. Who are the key botulism illness market companies?

Answer: Some of the key botulism illness companies are as follows:

• Allergan
• Pfizer
• AlphaVax
• Microbiotix
• Molecular Targeting Technologies
• Ipsen Technologies
• Galderma

Q5. Which botulism illness market segment will be the largest in future?

Answer: Lucintel forecasts that botulinum type A is expected to witness higher growth over the forecast period.

Q6. In botulism illness market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing awareness about the disease and easy availability of advanced treatment facilities in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the botulism illness market by toxin type (botulinum type A and botulinum type B), treatment type (antitoxins, meticulous airway management, cathartics, foley catheter, and others), drug distribution channel (retail pharmacy and online stores), end use (hospitals & clinics and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Botulism Illness Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Botulism Illness Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Botulism Illness Market by Toxin Type
  • 3.3.1: Botulinum Type A
  • 3.3.2: Botulinum Type B
• 3.4: Global Botulism Illness Market by Treatment Type
  • 3.4.1: Antitoxins
  • 3.4.2: Meticulous Airway Management
  • 3.4.3: Cathartics
  • 3.4.4: Foley catheter
  • 3.4.5: Others
• 3.5: Global Botulism Illness Market by Drug Distribution Channel
  • 3.5.1: Retail Pharmacy
  • 3.5.2: Online Stores
• 3.6: Global Botulism Illness Market by End Use
  • 3.6.1: Hospitals & Clinics
  • 3.6.2: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Botulism Illness Market by Region
• 4.2: North American Botulism Illness Market
  • 4.2.1: North American Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
  • 4.2.2: North American Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
• 4.3: European Botulism Illness Market
  • 4.3.1: European Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
  • 4.3.2: European Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
• 4.4: APAC Botulism Illness Market
  • 4.4.1: APAC Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
  • 4.4.2: APAC Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
• 4.5: ROW Botulism Illness Market
  • 4.5.1: ROW Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
  • 4.5.2: ROW Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Botulism Illness Market by Toxin Type
  • 6.1.2: Growth Opportunities for the Global Botulism Illness Market by Treatment Type
  • 6.1.3: Growth Opportunities for the Global Botulism Illness Market by Drug Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Botulism Illness Market by End Use
  • 6.1.5: Growth Opportunities for the Global Botulism Illness Market by Region
• 6.2: Emerging Trends in the Global Botulism Illness Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Botulism Illness Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Botulism Illness Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Allergan
• 7.2: Pfizer
• 7.3: AlphaVax
• 7.4: Microbiotix
• 7.5: Molecular Targeting Technologies
• 7.6: Ipsen Technologies
• 7.7: Galderma